Navigation Links
New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions
Date:9/13/2011

ORMOND BEACH, Fla., Sept. 13, 2011 /PRNewswire/ -- Florida-based SkinHealth Technology introduces a powerful, breakthrough formula that combines cutting-edge cosmeceutical ingredients -- peptides, polysaccharides and botanical emollients -- with a proven skin protectant to help combat even the most serious skin conditions. ExtremeSkinCare Intense Treatment Balm helps reduce the unsightly appearance of psoriasis, eczema, and rosacea and relieve inflamed and irritated skin without steroids.

Millions of Americans are affected by psoriasis, eczema, rosacea or other troublesome skin conditions, leaving them searching for a safe, effective topical treatment.

Dermatologist Jeffrey Parks, MD and a team of skincare experts have developed a formulation containing a perfect combination of ingredients that help reduce inflammation, redness and clear affected skin of plaques.

ExtremeSkinCare Intense Treatment Balm:

  • Helps reduce inflammation, redness, itching and irritation
  • Protects and relieves dry, cracked and scaling skin
  • Increases skin's resistance to further physical damage by 60%
  • Helps improve skin elasticity and stimulates collagen synthesis

SkinHealth Technology LLC, an R&D based development company which formulates advanced dermatological, therapeutic skincare products, was founded in 2008. Jeffrey Parks, MD and a team of skincare professionals develop effective formulas that address bruising, acne, vitamin D deficiency, sun damage and chronic skin conditions.

For more detailed information about ExtremeSkinCare Intense Treatment Balm or to schedule an interview, please contact Jack Surrette at 386.236.9949 or visit http://www.skinhealthtech.com.

Contact:

Jack Surrette
Executive Director
SkinHealth Technology LLC
P.O. Box 731626, Ormond Beach, FL 32173
386.236.9949 or jes@skinhealthtech.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE SkinHealth Technology LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
3. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
4. Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
5. Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space
6. Advanced Life Sciences Submits Full Proposal to NIAID for Development of Intravenous Formulation of Restanza as a Biodefense Countermeasure
7. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
8. Australian Patent Issued to CreAgri® for Ultraviolet Radiation (UVR) Protection by its Hydroxytyrosol-Based Formulations
9. Biosynthetic corneas formulated with recombinant collagen restore vision and nerve growth
10. Advanced Life Sciences Announces Successful Preclinical Data Supporting Restanza Intravenous Formulation for Hospital Use
11. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:6/20/2016)... , June 20, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... prisons involved, it has secured the final acceptance ... facilities for Managed Access Systems (MAS) installed. Furthermore, ... facilities to be installed by October, 2016. MAS ...
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
Breaking Biology News(10 mins):